NO985975L - Blandinger og fremgangsmÕter for frembringelse av farmakologisk aktive preparater og anvendelser derav - Google Patents
Blandinger og fremgangsmÕter for frembringelse av farmakologisk aktive preparater og anvendelser deravInfo
- Publication number
- NO985975L NO985975L NO985975A NO985975A NO985975L NO 985975 L NO985975 L NO 985975L NO 985975 A NO985975 A NO 985975A NO 985975 A NO985975 A NO 985975A NO 985975 L NO985975 L NO 985975L
- Authority
- NO
- Norway
- Prior art keywords
- pharmacologically active
- mixtures
- methods
- active preparations
- producing pharmacologically
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/82—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1608896P | 1996-06-20 | 1996-06-20 | |
| PCT/US1997/010643 WO1997048694A1 (fr) | 1996-06-20 | 1997-06-20 | Composes et procedes d'obtention de preparations pharmacologiquement actives et leurs utilisations |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO985975D0 NO985975D0 (no) | 1998-12-18 |
| NO985975L true NO985975L (no) | 1999-02-18 |
Family
ID=21775328
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO985975A NO985975L (no) | 1996-06-20 | 1998-12-18 | Blandinger og fremgangsmÕter for frembringelse av farmakologisk aktive preparater og anvendelser derav |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6720344B2 (fr) |
| EP (1) | EP0912549A4 (fr) |
| JP (1) | JP2000514048A (fr) |
| KR (1) | KR20000022040A (fr) |
| CN (1) | CN1226245A (fr) |
| AU (1) | AU727708B2 (fr) |
| BR (1) | BR9711805A (fr) |
| CA (1) | CA2258822A1 (fr) |
| HU (1) | HUP9904567A3 (fr) |
| IL (1) | IL127559A0 (fr) |
| NO (1) | NO985975L (fr) |
| PL (1) | PL330814A1 (fr) |
| WO (1) | WO1997048694A1 (fr) |
Families Citing this family (91)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001510450A (ja) * | 1996-10-23 | 2001-07-31 | ザイモジェネティクス，インコーポレイテッド | 骨欠損状態を処置するための組成物および方法 |
| US6376476B1 (en) | 1996-12-13 | 2002-04-23 | Zymogenetics Corporation | Isoprenoid pathway inhibitors for stimulating bone growth |
| US6670398B2 (en) | 1997-05-14 | 2003-12-30 | Atherogenics, Inc. | Compounds and methods for treating transplant rejection |
| DK0981343T3 (da) | 1997-05-14 | 2006-01-30 | Atherogenics Inc | Probucolmonoestere til behandling af kardiovaskulær og inflammatorisk sygdom |
| NZ505362A (en) * | 1997-12-22 | 2004-12-24 | Upjohn Co | 4-hydroxyquinoline-3-carboxamides and -hydrazides useful as antiviral agents |
| US6902721B1 (en) | 1998-07-10 | 2005-06-07 | Osteoscreen, Inc. | Inhibitors of proteasomal activity for stimulating bone growth |
| US6462019B1 (en) | 1998-07-10 | 2002-10-08 | Osteoscreen, Inc. | Inhibitors of proteasomal activity and production for stimulating bone growth |
| US6838436B1 (en) | 1998-07-10 | 2005-01-04 | Osteoscreen Inc. | Inhibitors of proteasomal activity for stimulating bone growth |
| US6780883B2 (en) | 1998-11-05 | 2004-08-24 | Warner-Lambert Company | Amide inhibitors of microsomal triglyceride transfer protein |
| AU8531101A (en) * | 2000-08-29 | 2002-03-13 | Nobex Corp | Immunoregulatory compounds and derivatives and methods of treating diseases therewith |
| ATE448226T1 (de) | 2000-09-01 | 2009-11-15 | Novartis Vaccines & Diagnostic | Aza heterocyclische derivate und ihre therapeutische verwendung |
| ATE309996T1 (de) | 2000-09-11 | 2005-12-15 | Chiron Corp | Chinolinonderivate als tyrosin-kinase inhibitoren |
| US20100074949A1 (en) | 2008-08-13 | 2010-03-25 | William Rowe | Pharmaceutical composition and administration thereof |
| US7642278B2 (en) | 2001-07-03 | 2010-01-05 | Novartis Vaccines And Diagnostics, Inc. | Indazole benzimidazole compounds |
| US8048924B2 (en) * | 2001-08-29 | 2011-11-01 | Biocon Limited | Methods and compositions employing 4-aminophenylacetic acid compounds |
| US7825132B2 (en) | 2002-08-23 | 2010-11-02 | Novartis Vaccines And Diagnostics, Inc. | Inhibition of FGFR3 and treatment of multiple myeloma |
| EP1539754A4 (fr) | 2002-08-23 | 2009-02-25 | Novartis Vaccines & Diagnostic | Quinolinones de benzimidazole et leurs utilisations |
| WO2004043389A2 (fr) | 2002-11-13 | 2004-05-27 | Chiron Corporation | Procedes de traitement du cancer et procedes connexes |
| AU2004209456A1 (en) * | 2003-02-03 | 2004-08-19 | Janssen Pharmaceutica N.V. | Quinoline-derived amide modulators of vanilloid VR1 receptor |
| JP4667384B2 (ja) | 2003-10-07 | 2011-04-13 | レノビス， インコーポレイテッド | イオンチャネルリガンドとしてのアミド誘導体および薬学的組成物、ならびにこれらを使用する方法 |
| EP1692085A4 (fr) | 2003-11-07 | 2010-10-13 | Novartis Vaccines & Diagnostic | Inhibition de recepteur fgfr3 et traitement de myelome multiple |
| CN1960731B (zh) | 2004-02-20 | 2011-12-07 | 诺华疫苗和诊断公司 | 调节炎性和转移过程的方法 |
| US8354427B2 (en) | 2004-06-24 | 2013-01-15 | Vertex Pharmaceutical Incorporated | Modulators of ATP-binding cassette transporters |
| DK1773816T3 (en) | 2004-06-24 | 2015-01-26 | Vertex Pharma | Modulators of ATP-binding cassette transporters |
| DK1773767T3 (en) | 2004-07-07 | 2016-03-21 | Biocon Ltd | Synthesis of azo bound in immune regulatory relations |
| US9512125B2 (en) | 2004-11-19 | 2016-12-06 | The Regents Of The University Of California | Substituted pyrazolo[3.4-D] pyrimidines as anti-inflammatory agents |
| PT1845990E (pt) | 2005-01-27 | 2011-12-23 | Novartis Vaccines & Diagnostic | Tratamento de tumores metastatizados |
| US7576099B2 (en) | 2005-02-28 | 2009-08-18 | Renovis, Inc. | Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| BRPI0610355A2 (pt) | 2005-05-17 | 2010-06-15 | Novartis Ag | métodos par sintetizar compostos heterocìclicos |
| KR20080074143A (ko) | 2005-11-29 | 2008-08-12 | 노파르티스 아게 | 퀴놀리논 제제 |
| US20090105272A1 (en) * | 2005-12-24 | 2009-04-23 | Grootenhuis Peter D J | Prodrugs of modulators of ABC transporters |
| JP5409010B2 (ja) | 2005-12-28 | 2014-02-05 | バーテックス ファーマシューティカルズ インコーポレイテッド | Ｎ−［２，４−ビス（１，１−ジメチルエチル）−５−ヒドロキシフェニル］−１，４−ジヒドロ−４−オキソキノリン−３−カルボキサミドの固体形態 |
| CA2647391C (fr) | 2006-04-04 | 2015-12-29 | The Regents Of The University Of California | Antagonistes de la kinase |
| PL2118074T3 (pl) | 2007-02-01 | 2014-06-30 | Resverlogix Corp | Związki chemiczne do celów profilaktyki i leczenia chorób układu sercowo-naczyniowego |
| US8252840B2 (en) | 2007-03-26 | 2012-08-28 | Salutria Pharmaceuticals Llc | Methods of derivatives of probucol for the treatment of type II diabetes |
| US20110160232A1 (en) | 2007-10-04 | 2011-06-30 | Pingda Ren | Certain chemical entities and therapeutic uses thereof |
| KR101897881B1 (ko) | 2008-01-04 | 2018-09-12 | 인텔리카인, 엘엘씨 | 특정 화학 물질, 조성물 및 방법 |
| US8193182B2 (en) * | 2008-01-04 | 2012-06-05 | Intellikine, Inc. | Substituted isoquinolin-1(2H)-ones, and methods of use thereof |
| WO2009114874A2 (fr) | 2008-03-14 | 2009-09-17 | Intellikine, Inc. | Inhibiteurs de kinases (benzothiazole) et procédés d’utilisation associés |
| US8637542B2 (en) * | 2008-03-14 | 2014-01-28 | Intellikine, Inc. | Kinase inhibitors and methods of use |
| NZ586440A (en) | 2008-06-26 | 2011-07-29 | Resverlogix Corp | Methods of preparing quinazolinone derivatives |
| WO2010006072A2 (fr) | 2008-07-08 | 2010-01-14 | The Regents Of The University Of California | Modulateurs de mtor et leurs utilisations |
| CN102124009B (zh) | 2008-07-08 | 2014-07-23 | 因特利凯公司 | 激酶抑制剂及其使用方法 |
| US8703778B2 (en) | 2008-09-26 | 2014-04-22 | Intellikine Llc | Heterocyclic kinase inhibitors |
| WO2010045542A2 (fr) | 2008-10-16 | 2010-04-22 | The Regents Of The University Of California | Inhibiteurs d'hétéroarylkinase à noyau fusionné |
| US8513282B2 (en) | 2008-10-23 | 2013-08-20 | Vertex Pharmaceuticals Incorporated | Modulators of cystic fibrosis transmembrane conductance regulator |
| US8476431B2 (en) | 2008-11-03 | 2013-07-02 | Itellikine LLC | Benzoxazole kinase inhibitors and methods of use |
| ES2463097T3 (es) | 2009-01-08 | 2014-05-27 | Resverlogix Corp. | Compuestos para la prevención y el tratamiento de enfermedades cardiovasculares |
| US9238640B2 (en) | 2009-03-18 | 2016-01-19 | Resverlogix Corp. | Anti-inflammatory agents |
| NZ624460A (en) | 2009-03-20 | 2015-12-24 | Vertex Pharma | Process for making modulators of cystic fibrosis transmembrane conductance regulator |
| NZ596117A (en) | 2009-04-22 | 2014-10-31 | Resverlogix Corp | Novel anti-inflammatory agents |
| JP5789252B2 (ja) | 2009-05-07 | 2015-10-07 | インテリカイン， エルエルシー | 複素環式化合物およびその使用 |
| WO2011047384A2 (fr) | 2009-10-16 | 2011-04-21 | The Regents Of The University Of California | Procédés d'inhibition de l'activité ire1 |
| EP2571357B1 (fr) | 2010-05-21 | 2016-07-06 | Infinity Pharmaceuticals, Inc. | Composés chimiques, compositions et procédés pour modulation de kinases |
| WO2011153531A1 (fr) | 2010-06-04 | 2011-12-08 | University Of South Florida | Procédé de traitement de dysplasies squelettiques mettant en œuvre un vasodilatateur |
| ES2553771T3 (es) | 2010-10-08 | 2015-12-11 | Nivalis Therapeutics, Inc. | Nuevos compuestos de quinolina sustituidos como inhibidores de la S-nitrosoglutatión reductasa |
| WO2012064973A2 (fr) | 2010-11-10 | 2012-05-18 | Infinity Pharmaceuticals, Inc. | Composés hétérocycliques et utilisations de ceux-ci |
| US8802700B2 (en) | 2010-12-10 | 2014-08-12 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-Binding Cassette transporters |
| WO2012083165A1 (fr) | 2010-12-16 | 2012-06-21 | N30 Pharmaceuticals, Llc | Nouveaux composés aromatiques bicycliques substitués en tant qu'inhibiteurs de la s-nitrosoglutathion réductase |
| US8809349B2 (en) | 2011-01-10 | 2014-08-19 | Infinity Pharmaceuticals, Inc. | Processes for preparing isoquinolinones and solid forms of isoquinolinones |
| US9295673B2 (en) | 2011-02-23 | 2016-03-29 | Intellikine Llc | Combination of mTOR inhibitors and P13-kinase inhibitors, and uses thereof |
| CN103930422A (zh) | 2011-07-19 | 2014-07-16 | 无限药品股份有限公司 | 杂环化合物及其用途 |
| JP6027611B2 (ja) | 2011-07-19 | 2016-11-16 | インフィニティー ファーマシューティカルズ， インコーポレイテッド | 複素環式化合物及びその使用 |
| AU2012302197B2 (en) | 2011-08-29 | 2016-01-07 | Infinity Pharmaceuticals Inc. | Heterocyclic compounds and uses thereof |
| MX370814B (es) | 2011-09-02 | 2020-01-08 | Univ California | Pirazolo[3,4-d]pirimidinas sustituidas y usos de las mismas. |
| HUE044986T2 (hu) | 2011-11-01 | 2019-11-28 | Resverlogix Corp | Orális, azonnali felszabadulású készítmények szubsztituált kinazolinonokhoz |
| CN104470518A (zh) | 2012-02-27 | 2015-03-25 | 沃泰克斯药物股份有限公司 | 药物组合物及其施用 |
| US8940742B2 (en) | 2012-04-10 | 2015-01-27 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| US8828998B2 (en) | 2012-06-25 | 2014-09-09 | Infinity Pharmaceuticals, Inc. | Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors |
| AU2013323426A1 (en) | 2012-09-26 | 2015-04-23 | The Regents Of The University Of California | Modulation of ire1 |
| WO2014080290A2 (fr) | 2012-11-21 | 2014-05-30 | Rvx Therapeutics Inc. | Amines cycliques servant d'inhibiteurs de bromodomaines |
| US9765039B2 (en) | 2012-11-21 | 2017-09-19 | Zenith Epigenetics Ltd. | Biaryl derivatives as bromodomain inhibitors |
| KR20150096794A (ko) | 2012-12-21 | 2015-08-25 | 제니쓰 에피제네틱스 코포레이션 | 브로모도메인 저해제로서의 신규한 헤테로사이클릭 화합물 |
| US9481667B2 (en) | 2013-03-15 | 2016-11-01 | Infinity Pharmaceuticals, Inc. | Salts and solid forms of isoquinolinones and composition comprising and methods of using the same |
| JP6466924B2 (ja) | 2013-10-04 | 2019-02-06 | インフィニティー ファーマシューティカルズ， インコーポレイテッド | 複素環式化合物及びその使用 |
| US9751888B2 (en) | 2013-10-04 | 2017-09-05 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| DK3119397T3 (da) | 2014-03-19 | 2022-03-28 | Infinity Pharmaceuticals Inc | Heterocykliske forbindelser til anvendelse i behandling af PI3K-gamma-medierede lidelser |
| WO2015160975A2 (fr) | 2014-04-16 | 2015-10-22 | Infinity Pharmaceuticals, Inc. | Polythérapies |
| WO2016025496A1 (fr) * | 2014-08-11 | 2016-02-18 | Lacerta Technologies Inc. | Facteur plaquettaire 4 destiné à être utilisé dans le traitement de maladies osseuses |
| CN113620978A (zh) | 2014-09-11 | 2021-11-09 | 加利福尼亚大学董事会 | mTORC1抑制剂 |
| WO2016054491A1 (fr) | 2014-10-03 | 2016-04-07 | Infinity Pharmaceuticals, Inc. | Composés hétérocycliques et leurs utilisations |
| CA2963945C (fr) | 2014-10-07 | 2023-01-10 | Vertex Pharmaceuticals Incorporated | Co-cristaux de modulateurs du regulateur de conductance transmembranaire de la mucoviscidose |
| CN114984016A (zh) | 2015-03-13 | 2022-09-02 | 雷斯韦洛吉克斯公司 | 用于治疗补体相关疾病之组合物及治疗方法 |
| WO2017044766A1 (fr) | 2015-09-10 | 2017-03-16 | Nivalis Therapeutics, Inc. | Formes solides d'un inhibiteur de s-nitrosoglutathione réductase |
| KR20180058741A (ko) | 2015-09-14 | 2018-06-01 | 인피니티 파마슈티칼스, 인코포레이티드 | 이소퀴놀리논의 고체형, 그의 제조 방법, 이를 포함하는 조성물 및 이를 사용하는 방법 |
| WO2017161116A1 (fr) | 2016-03-17 | 2017-09-21 | Infinity Pharmaceuticals, Inc. | Isotopologues de composés isoquinolinone et quinazolinone et leurs utilisations comme inhibiteurs de la kinase pi3k |
| US10919914B2 (en) | 2016-06-08 | 2021-02-16 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| CA3028718A1 (fr) | 2016-06-24 | 2017-12-28 | Infinity Pharmaceuticals, Inc. | Polytherapies |
| FI3788049T3 (fi) | 2018-05-01 | 2023-05-30 | Revolution Medicines Inc | C40-, c28- ja c-32-liittyneitä rapamysiinianalogeja mtor-estäjinä |
| IL312291A (en) | 2018-05-01 | 2024-06-01 | Revolution Medicines Inc | C-26-linked rapamycin analogs as MTOR inhibitors |
| CN109730999B (zh) * | 2018-12-28 | 2021-12-24 | 中山大学 | 噻唑苯甲酰胺衍生在制备抗骨质疏松、抗骨关节炎药物中的应用 |
Family Cites Families (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1148909A (en) * | 1965-04-19 | 1969-04-16 | Sumitomo Chemical Co | Process for production of novel phenylhydrazone and phenylhydrazine derivatives |
| LU63457A1 (fr) * | 1970-07-06 | 1971-11-12 | ||
| US4054574A (en) | 1976-05-24 | 1977-10-18 | Velsicol Chemical Corporation | 1-Benzothiazolyl-5-amino-imidazolidinones |
| DE2943125A1 (de) * | 1979-10-25 | 1981-05-14 | Troponwerke GmbH & Co KG, 5000 Köln | Verfahren zur herstellung von 1-(4-chlorbenzoyl)-5-methoxy-2-methyl-3-indol acetoxyessigsaeure |
| FR2509728A1 (fr) * | 1981-07-17 | 1983-01-21 | Roussel Uclaf | Nouveaux derives de la quinoleine, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant |
| US4560549A (en) * | 1983-08-24 | 1985-12-24 | Lever Brothers Company | Method of relieving pain and inflammatory conditions employing substituted salicylamides |
| US4607053A (en) * | 1984-05-17 | 1986-08-19 | E. R. Squibb & Sons, Inc. | Arylhydroxamates useful as antiallergy agents |
| FR2566407B1 (fr) * | 1984-06-25 | 1986-09-26 | Roussel Uclaf | Nouveaux derives de l'isoxazoloquinoleine, procede de preparation, application a titre de medicaments, et compositions les renfermant |
| JPS61225168A (ja) * | 1985-03-30 | 1986-10-06 | Nippon Tokushu Noyaku Seizo Kk | 新規ベンズアミド、その製法及び殺虫剤 |
| FR2583404B1 (fr) * | 1985-06-17 | 1990-04-13 | Pechiney Uranium | Procede de separation, par precipitation, du molybdene contenu dans des solutions de nitrate d'uranyle. |
| JPS62114976A (ja) * | 1985-11-13 | 1987-05-26 | Nippon Tokushu Noyaku Seizo Kk | 新規ベンズイミデ−ト類及び殺虫殺ダニ剤 |
| EP0261459A3 (fr) * | 1986-09-09 | 1988-05-11 | Nihon Tokushu Noyaku Seizo K.K. | N-benzothiazolylamides |
| DE3775363D1 (de) | 1986-10-22 | 1992-01-30 | Biotechnolog Forschung Gmbh | Wachstumstimulierendes material, herstellungsverfahren und therapeutische zusammensetzung. |
| FI91859C (fi) | 1987-06-17 | 1994-08-25 | Eisai Co Ltd | Analogiamenetelmä antiallergisena aineena aktiivisen bentsotiatsolijohdannaisen valmistamiseksi |
| JPH02501930A (ja) * | 1987-10-30 | 1990-06-28 | アクチエボラゲツト・ヘツスレ | 薬学的化合物のための新規な用途 |
| JPH01203325A (ja) * | 1988-02-08 | 1989-08-16 | Takeda Chem Ind Ltd | 骨粗鬆症予防治療剤 |
| US4874864A (en) * | 1988-05-24 | 1989-10-17 | Pfizer Inc. | Benzamide protease inhibitors |
| US4970318A (en) | 1988-05-24 | 1990-11-13 | Pfizer Inc. | Aromatic and heterocyclic carboxamide derivatives as antineoplastic agents |
| CA2015473C (fr) | 1989-04-28 | 1998-04-14 | Iwao Kinoshita | Derives de triphenylmethane |
| SE8902076D0 (sv) * | 1989-06-09 | 1989-06-09 | Pharmacia Ab | Derivatives of quinoline-3-carboxanilide |
| WO1990015801A1 (fr) | 1989-06-22 | 1990-12-27 | Pfizer Inc. | Sulfamides substitues et composes apparentes dans le traitement de l'asthme, de l'arthrite et des maladies apparentees |
| JPH03130216A (ja) * | 1989-07-21 | 1991-06-04 | Takeda Chem Ind Ltd | 骨吸収抑制剤 |
| JPH03181465A (ja) * | 1989-12-11 | 1991-08-07 | Takeda Chem Ind Ltd | キノリン誘導体 |
| JPH0717589B2 (ja) | 1990-01-22 | 1995-03-01 | ファイザー製薬株式会社 | 新規１，３―ジカルボニル化合物およびその組成物 |
| DE4014171A1 (de) | 1990-05-03 | 1991-11-07 | Basf Ag | Cyanochinolinverbindungen |
| DE69211723T2 (de) * | 1991-02-15 | 1996-10-31 | Takeda Chemical Industries Ltd | Mit einem Zellwachstumsfaktor bewirkte Anregung von Wachstum im Knocheninneren |
| US5525695A (en) | 1991-10-15 | 1996-06-11 | The Dow Chemical Company | Elastic linear interpolymers |
| US6277537B1 (en) | 1991-12-06 | 2001-08-21 | Eastman Kodak Company | Dye diffusion image separation systems with thermal solvents |
| TW366342B (en) * | 1992-07-28 | 1999-08-11 | Lilly Co Eli | The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss |
| WO1994003432A1 (fr) * | 1992-08-07 | 1994-02-17 | The Government Of The United States As Represented By The Secretary, Department Of Health And Human Services | Derives de 2-carboxylate de naphtyle polyhydroxyle et de 3-carboxylate de quinolyle et d'isoquinolyle utilises comme inhibiteurs de la proteine-tyrosine-kinase |
| US5322847A (en) | 1992-11-05 | 1994-06-21 | Pfizer Inc. | Azabenzimidazoles in the treatment of asthma, arthritis and related diseases |
| US5482949A (en) * | 1993-03-19 | 1996-01-09 | Eli Lilly And Company | Sulfonate derivatives of 3-aroylbenzo[b]thiophenes |
| EP0691849B1 (fr) * | 1993-03-29 | 1999-06-02 | ZymoGenetics, Inc. | Composition stimulant la croissance des osteoblastes contenant un facteur de croissance plaquettaire et de la vitamine d |
| GB9307014D0 (en) | 1993-04-02 | 1993-05-26 | Laporte Plc | Protecting group for use in oligodeoxyribonucleotide synthesis |
| US5468587A (en) | 1993-06-08 | 1995-11-21 | Eastman Kodak Company | Hydrogen bond accepting groups on thermal solvents for image separation systems |
| US5430144A (en) * | 1993-07-26 | 1995-07-04 | Merck & Co., Inc. | Benzo-fused lactams promote release of growth hormone |
| US5545735A (en) * | 1993-10-04 | 1996-08-13 | Merck & Co., Inc. | Benzo-Fused Lactams promote release of growth hormone |
| US5389646A (en) * | 1993-12-30 | 1995-02-14 | Zymogenetics, Inc. | Methods for treatment and prevention of bone loss using 2,3-benzopyrans |
| US5478847A (en) * | 1994-03-02 | 1995-12-26 | Eli Lilly And Company | Methods of use for inhibiting bone loss and lowering serum cholesterol |
| US5637598A (en) * | 1994-11-18 | 1997-06-10 | Eli Lilly And Company | Methods of inhibiting bone loss |
| US5665890A (en) | 1995-03-14 | 1997-09-09 | President And Fellows Of Harvard College | Stereoselective ring opening reactions |
| US5635197A (en) * | 1995-03-21 | 1997-06-03 | Eli Lilly And Company | Treatment and prevention of prostatic cancer metastasis |
| US5550134A (en) * | 1995-05-10 | 1996-08-27 | Eli Lilly And Company | Methods for inhibiting bone loss |
| CA2227198A1 (fr) | 1995-07-17 | 1997-02-06 | Peptide Therapeutics Limited | Inhibiteurs de la cysteine protease pour le traitement de maladies allergiques induites par l'immunoglobuline e (ige) |
| US5780300A (en) | 1995-09-29 | 1998-07-14 | Yale University | Manipulation of non-terminally differentiated cells using the notch pathway |
| WO1997015308A1 (fr) * | 1995-10-23 | 1997-05-01 | Zymogenetics, Inc. | Compositions et procedes pour le traitement des deficits osseux |
| ATE254472T1 (de) | 1996-03-25 | 2003-12-15 | Chemo Sero Therapeut Res Inst | Hemmstoff für die gefässneubildung, der den gewebefaktor-inhibitor (tfpi) enthält |
| US5945365A (en) | 1996-05-20 | 1999-08-31 | Fina Technology, Inc. | Stereorigid bis-fluorenyl metallocenes |
| FR2754818B1 (fr) | 1996-10-23 | 1999-03-05 | Cird Galderma | Nouveaux derives bi-aromatiques du dibenzofuranne et leur utilisation en medecine humaine ou veterinaire ainsi qu'en cosmetique |
| US6077669A (en) | 1997-11-04 | 2000-06-20 | Becton Dickinson And Company | Kit and method for fluorescence based detection assay |
| US5943585A (en) | 1997-12-19 | 1999-08-24 | Advanced Micro Devices, Inc. | Trench isolation structure having low K dielectric spacers arranged upon an oxide liner incorporated with nitrogen |
-
1997
- 1997-06-20 BR BR9711805-2A patent/BR9711805A/pt not_active Application Discontinuation
- 1997-06-20 KR KR1019980710438A patent/KR20000022040A/ko not_active Application Discontinuation
- 1997-06-20 EP EP97934849A patent/EP0912549A4/fr not_active Withdrawn
- 1997-06-20 HU HU9904567A patent/HUP9904567A3/hu unknown
- 1997-06-20 IL IL12755997A patent/IL127559A0/xx unknown
- 1997-06-20 PL PL97330814A patent/PL330814A1/xx unknown
- 1997-06-20 CA CA002258822A patent/CA2258822A1/fr not_active Abandoned
- 1997-06-20 WO PCT/US1997/010643 patent/WO1997048694A1/fr not_active Application Discontinuation
- 1997-06-20 JP JP10503338A patent/JP2000514048A/ja active Pending
- 1997-06-20 CN CN97196755A patent/CN1226245A/zh active Pending
- 1997-06-20 AU AU37917/97A patent/AU727708B2/en not_active Ceased
-
1998
- 1998-12-18 NO NO985975A patent/NO985975L/no not_active Application Discontinuation
-
2002
- 2002-03-27 US US10/108,606 patent/US6720344B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| PL330814A1 (en) | 1999-06-07 |
| AU727708B2 (en) | 2000-12-21 |
| JP2000514048A (ja) | 2000-10-24 |
| WO1997048694A1 (fr) | 1997-12-24 |
| US20030119791A1 (en) | 2003-06-26 |
| NO985975D0 (no) | 1998-12-18 |
| HUP9904567A2 (hu) | 2000-05-28 |
| EP0912549A4 (fr) | 2002-01-02 |
| CA2258822A1 (fr) | 1997-12-24 |
| IL127559A0 (en) | 1999-10-28 |
| KR20000022040A (ko) | 2000-04-25 |
| HUP9904567A3 (en) | 2001-10-29 |
| AU3791797A (en) | 1998-01-07 |
| BR9711805A (pt) | 2002-01-15 |
| US6720344B2 (en) | 2004-04-13 |
| CN1226245A (zh) | 1999-08-18 |
| EP0912549A1 (fr) | 1999-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO985975L (no) | Blandinger og fremgangsmÕter for frembringelse av farmakologisk aktive preparater og anvendelser derav | |
| DE69307340D1 (de) | Chinuclidin derivat als substanz p antagonist | |
| NO954611L (no) | Metoder og preparater for anvendelse i behandling av benigne gynekologiske sykdommer | |
| TR199901172T2 (xx) | Yeni ikame edilmi� pirazol t�revleri. | |
| IL112778A0 (en) | Substituted heterocycles, their preparation and pharmaceutical compositions containing them | |
| TR199901417T2 (xx) | Analjezik etkisi olan yeni bile�imler. | |
| IL125282A (en) | Substituted imidazole compounds, process for their preparation, pharmaceutical compositions containing them and use thereof in the preparation of medicaments for treating cytokine mediated diseases | |
| ES2168260T3 (es) | 3-aminoquinuclidinas sustituidas. | |
| DE69719798D1 (de) | Periphäre verabreichung von glp-1 analogen und derivate zur reguleirung der fettleibigkeit | |
| BG101806A (en) | Indole derivatives as 5-ht receptor antagoniss | |
| IL110672A0 (en) | Therapeutic heterocycles | |
| CY1105125T1 (el) | Χρηση αναστολεων ακετυλοχολινεστepασης για την παρασκευη φαρμακευτικων συνθεσεων για τη θepαπευτικη αντιμετωπιση συνδρομων λειτουργικων και/ή οργανικων πονων | |
| HU9602522D0 (en) | Heterocyclic compounds, their preparation and use | |
| EP0959896A4 (fr) | Compositions a base de recepteur de la thyrotropine humaine | |
| AU2284001A (en) | Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone | |
| NO983177L (no) | Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft | |
| ATE342721T1 (de) | Steroide als neurochemische stimulatoren des nasenraumes zur linderung der prämenstrualen symptome | |
| MXPA00010254A (es) | Tratamiento de disfuncion sexual en ciertos grupos de pacientes. | |
| DE68928752D1 (de) | Zubereitungen zur verwendung bei der behandlung von psoriasis und von neuropsychiatrischen krankheiten | |
| UA39179C2 (uk) | Фармацевтична композиція для лікування порушень серцевого ритму у великих ссавців та людей, спосіб її одержання та антиаритмічний лікарський засіб | |
| TR199901385T2 (xx) | Piperidin t�revleri. | |
| SE9502877D0 (sv) | Novel opioid peptides | |
| 王殿洪 et al. | PURIFICATION AND CHARACTERIZATION OF INSULIN RECEPTORS FROM HUMAN PLACENTA | |
| UA29005A (uk) | Спосіб лікування трофічних виразок нижніх кінцівок | |
| MX9710475A (es) | Utilizacion de al menos un agonista beta-adrenergico como antagonista de sustancia p. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |